MedDataX Logo

The Sugira Muryango PLAY Collaborative

NCT04257383 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1333

Last updated 2025-04-15

No results posted yet for this study

Summary

The Research Program on Children and Adversity (RPCA) has successfully grown its evidence-based home-visiting program-Sugira Muryango (SM)-in Rwanda, as policies and programs aligned with the Rwandan social protection system have evolved. The current study submission seeks to test an evidence-based implementation strategy, the PLAY Collaborative, to engage local stakeholders and frontline providers and supervisors to ensure quality improvement and sustainability of Sugira Muryango and to repeat our previous intervention to include Ubudehe 1 families with children 0-36 months in Nyanza, Ngoma, and Rubavu Districts in Rwanda.

Conditions

  • Child Development
  • Parenting
  • Parent-Child Relations
  • Child Malnutrition

Interventions

OTHER

Sugira Muryango

Strong Families, Thriving Children "Sugira Muryango" is a home-visiting intervention that empowers low-income families enrolled in Rwanda's social protection system to support early childhood development and healthy family functioning.

Sponsors & Collaborators

  • FXB

    collaborator UNKNOWN

  • Laterite

    collaborator UNKNOWN

  • LEGO

    collaborator UNKNOWN

  • Grand Challenges Canada

    collaborator OTHER

  • Echidna Giving

    collaborator UNKNOWN

  • The ELMA Foundation

    collaborator OTHER

  • InfaCare Pharmaceuticals Corporation, a Mallinckrodt Company

    collaborator INDUSTRY

  • Boston College

    lead OTHER

Principal Investigators

  • Theresa Betancourt, Sc.D · Boston College School of Social Work

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-05-05
Primary Completion
2022-11-04
Completion
2023-12-31

Countries

  • Rwanda

Study Locations

Related Clinical Trials

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04257383 on ClinicalTrials.gov